These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 28181243)

  • 1. Proteasome dysfunction in cardiomyopathies.
    Gilda JE; Gomes AV
    J Physiol; 2017 Jun; 595(12):4051-4071. PubMed ID: 28181243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-proteasome system and hereditary cardiomyopathies.
    Schlossarek S; Frey N; Carrier L
    J Mol Cell Cardiol; 2014 Jun; 71():25-31. PubMed ID: 24380728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ubiquitin proteasome system in human cardiomyopathies and heart failure.
    Day SM
    Am J Physiol Heart Circ Physiol; 2013 May; 304(10):H1283-93. PubMed ID: 23479263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants.
    Sarikas A; Carrier L; Schenke C; Doll D; Flavigny J; Lindenberg KS; Eschenhagen T; Zolk O
    Cardiovasc Res; 2005 Apr; 66(1):33-44. PubMed ID: 15769446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy.
    Carrier L; Schlossarek S; Willis MS; Eschenhagen T
    Cardiovasc Res; 2010 Jan; 85(2):330-8. PubMed ID: 19617224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies.
    Predmore JM; Wang P; Davis F; Bartolone S; Westfall MV; Dyke DB; Pagani F; Powell SR; Day SM
    Circulation; 2010 Mar; 121(8):997-1004. PubMed ID: 20159828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy.
    Bahrudin U; Morisaki H; Morisaki T; Ninomiya H; Higaki K; Nanba E; Igawa O; Takashima S; Mizuta E; Miake J; Yamamoto Y; Shirayoshi Y; Kitakaze M; Carrier L; Hisatome I
    J Mol Biol; 2008 Dec; 384(4):896-907. PubMed ID: 18929575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities.
    Schlossarek S; Mearini G; Carrier L
    J Mol Cell Cardiol; 2011 Apr; 50(4):613-20. PubMed ID: 21291890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ubiquitin-proteasome system in cardiac physiology and pathology.
    Powell SR
    Am J Physiol Heart Circ Physiol; 2006 Jul; 291(1):H1-H19. PubMed ID: 16501026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophy.
    Schlossarek S; Englmann DR; Sultan KR; Sauer M; Eschenhagen T; Carrier L
    Basic Res Cardiol; 2012 Jan; 107(1):235. PubMed ID: 22189562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of ubiquitin-proteasome system by E334K cMyBPC modifies channel proteins, leading to electrophysiological dysfunction.
    Bahrudin U; Morikawa K; Takeuchi A; Kurata Y; Miake J; Mizuta E; Adachi K; Higaki K; Yamamoto Y; Shirayoshi Y; Yoshida A; Kato M; Yamamoto K; Nanba E; Morisaki H; Morisaki T; Matsuoka S; Ninomiya H; Hisatome I
    J Mol Biol; 2011 Nov; 413(4):857-78. PubMed ID: 21939669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ubiquitin-proteasome system may be involved in the pathogenesis of hypertrophic cardiomyopathy.
    Vosberg HP
    Cardiovasc Res; 2005 Apr; 66(1):1-3. PubMed ID: 15769440
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hereditary cardiomyopathies: a review. Mutation of structural proteins a common cause of hereditary cardiomyopathy].
    Sjöberg G; Kostareva A; Sejersen T
    Lakartidningen; 2005 Mar 14-20; 102(11):845-7, 850-3. PubMed ID: 15835520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ubiquitin Proteasome System in Ischemic and Dilated Cardiomyopathy.
    Spänig S; Kellermann K; Dieterlen MT; Noack T; Lehmann S; Borger MA; Garbade J; Barac YD; Emrich F
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31861129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the ubiquitin proteasome system in diabetic cardiomyopathy.
    Bozi LHM; Campos JC
    J Mol Cell Cardiol; 2017 Aug; 109():61-63. PubMed ID: 28666620
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiac proteasome functional insufficiency plays a pathogenic role in diabetic cardiomyopathy.
    Li J; Ma W; Yue G; Tang Y; Kim IM; Weintraub NL; Wang X; Su H
    J Mol Cell Cardiol; 2017 Jan; 102():53-60. PubMed ID: 27913284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E3 ubiquitin ligase Asb2β is downregulated in a mouse model of hypertrophic cardiomyopathy and targets desmin for proteasomal degradation.
    Thottakara T; Friedrich FW; Reischmann S; Braumann S; Schlossarek S; Krämer E; Juhr D; Schlüter H; van der Velden J; Münch J; Patten M; Eschenhagen T; Moog-Lutz C; Carrier L
    J Mol Cell Cardiol; 2015 Oct; 87():214-24. PubMed ID: 26343497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes.
    Xu Q; Dewey S; Nguyen S; Gomes AV
    J Mol Cell Cardiol; 2010 May; 48(5):899-909. PubMed ID: 20298698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy and the ubiquitin-proteasome system in cardiac dysfunction.
    Zheng Q; Wang X
    Panminerva Med; 2010 Mar; 52(1):9-25. PubMed ID: 20228723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin-proteasome system: focus on the heart.
    Zolk O; Schenke C; Sarikas A
    Cardiovasc Res; 2006 Jun; 70(3):410-21. PubMed ID: 16497285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.